Telix said Part 1 of the ProstACT Global Phase 3 study met its primary objectives for TLX591-Tx in mCRPC. The company reported acceptable safety, no new safety signals and progression plans for Part 2.
Sanofi's oral BTK inhibitor rilzabrutinib received orphan drug designation in Japan for IgG4-related disease and warm autoimmune hemolytic anemia, while also securing U.S. FDA breakthrough therapy designation for the rare anemia indication.
Japan's Ministry of Health, Labour and Welfare has granted orphan drug designation to Sanofi's rilzabrutinib for IgG4-related disease, marking the third global orphan designation for this indication based on positive phase 2 study data.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07084532 |
Effects of Chewing Gum for Dry Mouth in Diabetes |
COMPLETED | NA |
| NCT06900621 |
Effects of Methods on Dry Mouth After Septoplasty Surgery |
NOT_YET_RECRUITING | NA |
| NCT06763133 |
The Effect of Cold Water Spray Application on Dry Mouth and Thirst Symptoms and Comfort of Patients After Endonasal Endoscopic Surgery After Admission to Intensive Care Unit |
COMPLETED | NA |
| NCT06708195 |
Efficacy of Transcutaneous Electrical Nerve Stimulation in Patients With Xerostomia (ETENX) |
COMPLETED | NA |
| NCT06555029 |
Oral Health Intervention in Adult Primary Care |
RECRUITING | NA |
| NCT06412627 |
The Effect of Intervention About Dry Mouth and Thirst in Patients With Endotracheal Tube |
NOT_YET_RECRUITING | NA |
| NCT06258603 |
Oral Care of Intubated Intensive Care Patient |
COMPLETED | NA |
| NCT06240806 |
Efficacy of Manuka Honey Oral Rinse in Treatment of Xerostomia |
COMPLETED | NA |
| NCT05964959 |
A Mouth Education Program for Dry Mouth |
COMPLETED | NA |
| NCT05871580 |
Effect to the Photobiomodulation in the Burning Mouth Syndrome |
COMPLETED | NA |
